Close

The Medicines Company (MDCO) PT Lifted to $65 at Chardan Capital Markets

March 21, 2016 7:34 AM EDT Send to a Friend
Chardan Capital Markets analyst Gbola Amusa reiterated a Buy rating and raised its price target on The Medicines Company (NASDAQ ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login